+1-786-628-7980
Sign Up/Sign In 
Market Overview
Optical Genome Mapping Market Research Report Information by Product (Instruments, Consumables and Reagents, Software, and Services), by Application (Structural Variant Detection, Genome Assembly, Microbial Strain Typing, and Others), by End-User (Biotechnology and Pharmaceutical Companies, Clinical Laboratories, Academic Research Institutes, and Others), And By Region (North America, Europe, Asia-Pacific, And Rest of The World) –Market Forecast Till 2032.
Optical Genome Mapping Market Size was valued at USD 0.12 Billion in 2022. The Optical Genome Mapping Market industry is projected to grow from USD 0.15 Billion in 2023 to USD 1.15 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 28.60% during the forecast period (2024 – 2032).
Get Free Sample PDF Brochure @ https://www.marketresearchfuture.com/sample_request/21544
Market Dynamics
The Compound Annual Growth Rate (CAGR) of the Optical Genome Mapping market is driven by increasing investments in research and development by major industry participants, along with enhanced partnerships between academic institutions and industrial partners. Government initiatives are also propelling market growth, such as the ‘Genome India: Cataloguing the Genetic Variation in Indians’ project sanctioned by the Government of India, Ministry of Science & Technology in March 2020, as reported by the Press Information Bureau. This project focuses on Whole Genome Sequencing (WGS) and aims to sequence the genomes of 10,000 individuals over three years, representing India’s diverse population. Optical genome mapping has paved the way for whole-genome sequencing by aiding genome assembly through aligning sequenced DNA fragments to the genome map. The insights gained from whole-genome sequencing are expected to significantly improve the accuracy of future human genetics research in India. Furthermore, it will facilitate the development of a genome-wide association array specifically tailored to the Indian population, leading to cost-effective precision healthcare and diagnostics for common diseases.
Industry players are employing various marketing strategies, including mergers, acquisitions, and product launches. For instance, in June 2022, Hamilton and Bionano Genomics, Inc. announced a collaboration to develop the Long String VANTAGE, designed to isolate Ultra High Molecular Weight (UHMW) DNA for optical genome mapping (OGM). Extracting high-quality and high-quantity UHMW DNA, a crucial step in Bionano’s sample preparation workflow, is traditionally performed manually by skilled laboratory personnel, which limits the amount of DNA extracted and its usability in regular sample preparation. As a result, the demand for the Optical Genome Mapping Market is expected to grow throughout the projection period due to increased R&D investment by major market players and strengthened partnerships between academic and industrial entities. This, in turn, will drive revenue growth in the Optical Genome Mapping Market.
Buy Now Premium Research Report: https://www.marketresearchfuture.com/checkout?currency=one_user-USD&report_id=21544
Segment Analysis
The global Optical Genome Mapping Market is segmented by Product, Application, and End-User.
Product Segment: The market is divided into Instruments, Consumables and Reagents, Software, and Services. In 2023, the Services segment held the largest market share. The optical genome mapping (OGM) sector is experiencing robust growth due to increased demand, ongoing advancements, versatile applications, and its critical role in the progression of genomics research. Various end-users are increasingly seeking OGM services for both research and clinical purposes. As genomics research evolves and new challenges emerge, the need for advanced OGM services is expected to grow significantly.
Application Segment: The market is categorized into Structural Variant Detection, Genome Assembly, Microbial Strain Typing, and Others. In 2023, the Structural Variant Detection segment was anticipated to hold the largest market share. Structural variants (SVs) represent significant genomic alterations that can affect health, influencing susceptibility to genetic diseases and treatment responses. Optical genome mapping, with its high-resolution imaging and ability to analyze individual DNA molecules, is particularly suited for detecting SVs. According to research published by Springer Nature Limited in March 2021, the total number of SVs identified per genome has surged, highlighting the increasing importance of OGM in this field. Contributions from the Pan-Cancer Analysis of Whole Genomes (PCAWG) Consortium have also identified significant gaps in cancer variant databases.
End-User Segment: The market is segmented into Biotechnology and Pharmaceutical Companies, Clinical Laboratories, Academic Research Institutes, and Others. In 2023, the Academic Research Institutes segment was expected to hold the largest market share. These institutions are increasingly adopting OGM technologies to advance their genomics research. Researchers in genetics, molecular biology, and biotechnology are continuously seeking tools that provide a deeper understanding of genomes. For instance, in April 2021, the significance of OGM technology was emphasized at the American College of Medical Genetics and Genomics’ annual meeting, demonstrating its effectiveness in a study involving 100 Acute Myeloid Leukemia (AML) patients.
Browse In-depth Market Research Report (128 Pages) on Optical Genome Mapping: https://www.marketresearchfuture.com/reports/optical-genome-mapping-market-21544
Regional Analysis
The global Optical Genome Mapping Market is divided into North America, Europe, Asia-Pacific, and Rest of the World.
North America: North America, comprising the US and Canada, held the largest market share. The region is a leader in genomics research and biotechnological advancements, with significant contributions from OGM. Factors driving market growth include the presence of leading biotech and pharmaceutical companies, substantial government funding for genomics research, and a robust healthcare infrastructure. For example, in September 2019, the National Institutes of Health awarded USD 29.5 million to maintain a comprehensive human genome reference sequence. The prevalence of genetic diseases and demand for personalized medicine are also driving the adoption of OGM technologies.
Europe: The European market has been growing steadily, driven by a focus on precision medicine, companion diagnostics, and advancements in genome analysis methodologies. The incidence of new cancer cases and related deaths is increasing, highlighting the need for oncology precision medicine and driving market growth. According to the European Cancer Information System (ECIS), the incidence of cancer and cancer-related deaths has risen, with significant percentages of men and women affected before age 75.
Asia-Pacific: The Asia-Pacific region is experiencing positive growth due to the rising prevalence of genetic disorders and chronic ailments, including cancer. For instance, the Indian Council of Medical Research’s National Cancer Registry Programme reported a significant number of cervical cancer cases in India in 2023. Additionally, China has seen an increase in its five-year cancer survival rate, indicating advancements in healthcare.
Rest of the World: The market in the Middle East, Africa, and Latin America is growing due to increased investments in healthcare infrastructure and research capabilities. Governments and private sector entities are establishing genomic research centers, fostering academic partnerships, and funding genomics research, thereby expanding the Optical Genome Mapping market and promoting the adoption of advanced technologies.
Competitive Dynamics
MRFR recognizes the following companies as the key players in the global Optical Genome Mapping Market— Bionano Genomics, Nucleome Informatics Private Limited, Praxis Genomics, LLC, SourceBio International Limited (Source BioScience), MedGenome, INRAE (French Plant Genomic Resources Center (CNRGV)), PerkinElmer (PerkinElmer Genomics), Genohub Inc., Hofkens Lab, Cerba.
Discover More Research Reports on Healthcare Industry by Market Research Future:
Nucleotide Market Research Report Information By Technology (TaqMan Allelic Discrimination, SNP by Pyrosequencing, Gene Chips & Microarrays and Others), By Application (Food & Beverage Additive, Pharmaceuticals, Diagnostics Research, Animal Feed Additive, and Others) And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2032.
HLA Typing Market Research Report Information By Technology (Molecular Assay Technologies, Non-molecular Assay Technologies), By Product & Service (Reagents & Consumables, Instruments, Software & Services), By Application (Diagnostic Applications, Research Applications, Donor-recipient cross-matching, Infectious disease testing, Cancer diagnosis & prevention, Transfusion therapy, Other diagnostic applications), By End-user (Commercial service providers, Hospitals & surgical centers, Research laboratories & academic institutes).
Microplate Reader Market Research Report Information By Product (Single-mode Readers, Multi-mode Readers), By Application (Genomics & Proteomics Research, Drug Discovery, Clinical Diagnostics, Others), By End-user (Pharmaceutical & Biotechnology Companies & CROs, Academic & Research Institutions, Others), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2032.
Global Cell Cryopreservation Market Research Report Information By Type (Cell Freezing Media, Equipment, Consumables, and Others), By Application (Stem Cells, oocyte cells, Sperm Cells, and Others), By End User (Pharmaceutical and Biotechnology Companies, Research Institute, Biobanks, IVF Clinics, and Others), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2032.
Hematopoietic Stem Cell Transplantation Market Research Report Information by Transplant Type (Allogeneic and Autologous), by Indication (Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Multiple Myeloma, Other Non-Malignant Disorders), by Application (Bone Marrow Transplant, Peripheral Blood Stem Cells Transplant, and Cord Blood Transplant), And By Region (North America, Europe, Asia-Pacific, And Rest of The World) –Market Forecast Till 2032.
About Market Research Future:
Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.
Contact:
Market Research Future (Part of Wantstats Research and Media Private Limited)
99 Hudson Street, 5Th Floor
New York, NY 10013
United States of America
+1 628 258 0071 (US)
+44 2035 002 764 (UK)
Email: sales@marketresearchfuture.com
Website: https://www.marketresearchfuture.com
